CALR c.299A>C ;(p.E100A)

Variant ID: 19-13050347-A-C

NM_004343.3(CALR):c.299A>C;(p.E100A)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Manipulation of cellular GSH biosynthetic capacity via TAT-mediated protein transduction of wild-type or a dominant-negative mutant of glutamate cysteine ligase alters cell sensitivity to oxidant-induced cytotoxicity.

Toxicology And Applied Pharmacology
Backos, Donald S DS; Brocker, Chad N CN; Franklin, Christopher C CC
Publication Date: 2010-02-15

Variant appearance in text: SSA: E100A
PubMed Link: 19914271
Variant Present in the following documents:
  • Main text
View BVdb publication page